Any news ??, up in NY 8%, page-14

@pierre77

Phase 2 trials to begin enrollment in the 2nd half of 2021. That has been announced at least twice, the first time being when they announced the Michael J Fox Foundation grant. The whole purpose of the BioMUSE study was to guide the design of the Phase 2 trials. So once the Phase 2 trials start the BioMUSE study is irrelevant in that regard.

I can't remember which announcement it was, but they were also looking at extending the BioMUSE study to run in parallel with the Phase 2 study, but I have not seen anything to suggest that is going to happen. This would presumably be to help with the design of Phase 3 trials.

So my original statement is in fact correct, and not misleading.

And perhaps you should pay more attention, you spelt my name wrong!!!